LNC
PJP icon

Lincoln National Corp’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Lincoln National Corp’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,696
Closed -$237K – 584
2017
Q4 		$237K Buy
+3,696
New +$237K 0.01% 559

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $508M AUM 36.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Lincoln National Corp's PJP Position: Q1 2018 in Review

Lincoln National Corp sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2018, closing a stake of 3,696 shares — an estimated $237K sold.

Lincoln National Corp first reported a position in PJP in Q4 2017 and held it in 1 quarter. The position peaked at $237K in Q4 2017. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2018.

  • Lincoln National Corp reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
  • Lincoln National Corp sold 3,696 Invesco Pharmaceuticals ETF shares in Q1 2018, an estimated $237K.
  • Lincoln National Corp first reported a position in Invesco Pharmaceuticals ETF in Q4 2017 and held it in 1 quarter.
  • Lincoln National Corp's Invesco Pharmaceuticals ETF position peaked at $237K in Q4 2017.
  • 96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2018.

Based on Lincoln National Corp's 13F filing for Q1 2018, filed 9 May 2018.